Randomised Clinical Trial of Adjuvant Chemotherapy in Patients with Node-Negative, Fast-Proliferating Breast Cancer

This publication has 8 references indexed in Scilit:

• Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients.
  Journal of Clinical Oncology, 1992
• How To Use Prognostic Factors in Axillary Node-Negative Breast Cancer Patients
  JNCI Journal of the National Cancer Institute, 1990
• TUMOR-PROLIFERATIVE ACTIVITY, PROGESTERONE-RECEPTOR STATUS, ESTROGEN-RECEPTOR LEVEL, AND CLINICAL OUTCOME OF ESTROGEN RECEPTOR-POSITIVE ADVANCED BREAST-CANCER
  1990
• The Multicenter Morphometric Mammary Carcinoma Project (MMMCP): A Nationwide Prospective Study on Reproducibility and Prognostic Power of Routine Quantitative Assessments in the Netherlands
  Pathology - Research and Practice, 1989
• Cell kinetics as a prognostic indicator in node-negative breast cancer
  European Journal of Cancer and Clinical Oncology, 1989
• Proliferative index of breast carcinoma by thymidine labeling: Prognostic power independent of stage, estrogen and progesterone receptors
  Breast Cancer Research and Treatment, 1988
• Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin.
  Journal of Clinical Oncology, 1988
• The DNA labelling index: A prognostic factor in node-negative breast cancer
  Breast Cancer Research and Treatment, 1987